Pattern and Distribution of Cancer Cases in Marib, Yemen, during 2022/2023
DOI:
https://doi.org/10.54582/TSJ.2.2.76Keywords:
Cancer, Marib, Yemen, Age, Sex, SiteAbstract
Background: Cancer is a global public health issue with a higher mortality rate than other diseases. Cancer has become a significant public health problem in Yemen and the ongoing influence of conflict has led to a decline in cancer care. This study is aimed to describe the patterns of cancer among 172 cases in Marib, Yemen, between 2022/2023.
Methods: Detailed information on 172 cases was collected from the histopathological records of patients registered in the Department of Histopathology at the National Center for Public Health Laboratories, Marib, Yemen, between January 2022 and December 2023. These cases were calculated based on sex, age, and tumor location, and separate analyses were performed for the major cancer types.
Results: The results showed that a total of 172 cancers were included, 40.7% were males and 59.3% female with a female -to- male ratio of 1.5:1. The most frequent cancer in the Yemeni population in Marib was colorectal cancer (n = 26, 15.1%), followed by breast cancer (n = 24, 14%), lymphoma (n = 17, 9.9%), head and neck cancer (n = 15, 8.7%), and gastric cancer (n = 14, 8.1%). The most common cancer among males was colorectal cancer (n =15, 8.7%), while females had breast cancer (n = 23, 13.4%).
Conclusion: Our findings showed that gastrointestinal tract cancers were the most frequent sites of cancer in general and breast cancers in females. Colorectal and gastric cancers were the most frequent types in males. This may explain why healthcare collapse with ongoing conflict and pesticide use has been observed in agricultural products, including khat. Marib should have an oncology center with essential diagnostic and therapeutic services that are freely available to all cancer patients.
Downloads
Published
How to Cite
Issue
Section
License
Copyright and Licensing
This journal publishes all scientific materials under the Creative Commons Attribution 4.0 International (CC BY 4.0) , license, which grants you the following permissions:
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.





